ACM
PTCT icon

Aquatic Capital Management’s PTC Therapeutics PTCT Stock Holding History

Aquatic Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81M Buy
83,470
+63,543
+319% +$4.59M 0.23% 94
2026
Q1 		$1.36M Buy
+19,927
New +$1.41M 0.04% 480
2025
Q3 		– Sell
-8,420
Closed -$411K – 1608
2025
Q2 		$411K Sell
8,420
-9,004
-52% -$427K 0.01% 875
2025
Q1 		$888K Sell
17,424
-52,445
-75% -$2.62M 0.02% 629
2024
Q4 		$3.15M Buy
69,869
+59,569
+578% +$2.55M 0.09% 282
2024
Q3 		$382K Sell
10,300
-20,400
-66% -$683K 0.01% 696
2024
Q2 		$939K Buy
+30,700
New +$995K 0.03% 409
2024
Q1 		– Sell
-21,200
Closed -$584K – 1565
2023
Q4 		$584K Buy
21,200
+18,300
+631% +$418K 0.01% 598
2023
Q3 		$65K Sell
2,900
-13,000
-82% -$483K ﹤0.01% 916
2023
Q2 		$647K Buy
+15,900
New +$778K 0.04% 398
2022
Q4 		– Sell
-12,800
Closed -$643K – 1731
2022
Q3 		$643K Buy
+12,800
New +$627K 0.06% 352

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Aquatic Capital Management's PTCT Position: Q2 2026 in Review

Aquatic Capital Management increased its PTC Therapeutics (PTCT) stake by 319% in Q2 2026, buying an estimated $4.59M and bringing the position to 83,470 shares worth $6.81M. The position accounts for 0.23% of the portfolio, ranked #94.

Aquatic Capital Management first reported a position in PTCT in Q3 2022 and has held it in 11 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Aquatic Capital Management held 83,470 shares of PTC Therapeutics worth $6.81M as of Q2 2026.
  • Aquatic Capital Management bought 63,543 PTC Therapeutics shares in Q2 2026, an estimated $4.59M.
  • PTC Therapeutics made up 0.23% of Aquatic Capital Management's portfolio in Q2 2026, its #94 holding.
  • Aquatic Capital Management first reported a position in PTC Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.